Home / Resource Library / Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma

Article discusses the use of BTK combined with BCL2 inhibitors in treating CLL and mantle cell lymphoma.